AI assistant
ARTIVION, INC. — Director's Dealing 2013
Feb 19, 2013
31684_dirs_2013-02-19_0f100879-3111-4e7a-8209-ce930d48a915.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CRYOLIFE INC (CRY)
CIK: 0000784199
Period of Report: 2013-02-15
Reporting Person: Capps Scott B (VP-Clinical Research)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-15 | Common Stock | A | 10000 | — | Acquired | 61773 | Direct |
| 2013-02-15 | Common Stock | A | 10430 | — | Acquired | 72203 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-15 | Stock Option (Right to Buy) | $6.12 | A | 10000 | Acquired | 2020-02-15 | Common Stock (10000) | Direct |
Footnotes
F1: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company.
F2: Represents performance shares granted on March 7, 2012 and earned at 125% of target based on 2012 adjusted EBITDA. The shares will vest 50% on the first anniversary of the grant date, 25% on the second anniversary of the grant date and 25% on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company.
F3: Stock option vests 33 1/3% per year beginning on first anniversary of grant date.